1 completed, 1 suspended, 1 terminated. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 1, Suspended 1, Terminated 1 |
Follow Coronary Thrombosis: new trials by email Literature Review of Coronary Thrombosis trials Research Report on Coronary Thrombosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Efficacy and Safety of GNR-060 vs Metalyse in Patients With ST Elevation Myocardial Infarction GNR-060, Metalyse - ST Elevation Myocardial Infarction | Phase 3 | Completed | AO GENERIUM | 244 | 2021-09-03 | 2026-09-21 |
| Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1) CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin, Plavix (clopidogrel 75 mg) and aspirin - Acute Coronary Syndrome, Myocardial Infarction | Phase 3 | Terminated | Cogentus Pharmaceuticals | 5000 | 2007-12-01 | 2009-01-28 |
| Veliflapon (DG-031)to Prevent Heart Attacks or Stroke in Patients With a History of Heart Attack or Unstable Angina veliflapon (DG-031) - Acute Coronary Syndrome | Phase 3 | Suspended | deCODE genetics | 3450 | 2006-05-01 | 2006-11-29 |
Myocardial Infarction (3) · Acute Coronary Syndrome (2) · Coronary Artery Disease (2) · Myocardial Ischemia (2) · ST Elevation Myocardial Infarction (2) · Angina, Unstable (1) · Cerebrovascular Disorders (1) · Duodenal Obstruction (1) · Duodenal Ulcer (1) · Dyspepsia (1) · Esophagitis, Peptic (1) · Gastric Outlet Obstruction (1) · Gastroesophageal Reflux (1) · Gastrointestinal Hemorrhage (1)
Cardiovascular Diseases (3) · Coronary Disease (3) · Embolism and Thrombosis (3) · Heart Diseases (3) · Infarction (3) · Ischemia (3) · Necrosis (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Thrombosis (3) · Vascular Diseases (3) · Arterial Occlusive Diseases (2) · Arteriosclerosis (2) · Brain Diseases (2) · Central Nervous System Diseases (2)
2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid (1) · Aspirin (1) · Clopidogrel (1) · Omeprazole (1) · Tenecteplase (1)
AO GENERIUM (1) · Cogentus Pharmaceuticals (1) · deCODE genetics (1)
United States (2) · Australia (1) · Bulgaria (1) · Canada (1) · Chile (1) · Czechia (1) · France (1) · Germany (1) · Hungary (1) · Italy (1) · Mexico (1) · Poland (1) · Puerto Rico (1) · Romania (1) · Russia (1)
Christopher Granger, M.D. (1) · Douglas W Weaver, M.D. (1) · Oksana A. Markova, MD, MSc (1) · Pablo Lapuerta, MD (1)